|
1
Tobert, J.A. Lovastatin and beyond: The history of the HMG-CoA reductase inhibitors. Nature Reviews Drug Discovery 2 517-526 (2003).
2
Istvan, E.S., Deisenhofer, J. Structural mechanism for statin inhibition of HMG-CoA reductase. Science 292 1160-1164 (2001).
3
Corsini, A., Maggi, F.M., Catapano, A.L. Pharmacology of competitive inhibitors of HMG-CoA reductase. Pharmacol Res 31(1) 9-27 (1995).
4
Serruys, P.W.J.C., de Feyter, P., Macaya, C., et al. Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: A randomized controlled trial. JAMA 287(24) 3215-3222 (2002).
|